Neurol. praxi. 2010;11(5):327-330

Pyridoxine-dependent epilepsy - new trends in diagnosis and treatment

MUDr.Štefania Rusnáková1, RNDr.Lenka Fajkusová, CSc.2, Mgr.Eva Jansová, Ph.D.2, Mgr.Pavla Šultesová2, MUDr.Lia Elstnerová3, doc.MUDr.Dalibor Valík, Ph.D.4, doc.MUDr.Hana Ošlejšková, Ph.D.1
1 Klinika dětské neurologie LF MU a FN Brno, Centrum pro epilepsii, Brno
2 Centrum molekulární biologie a genové terapie Interní hematoonkologické kliniky LF MU a FN, Brno
3 Pediatrická klinika, Neonatologické oddělení, LF MU a FN, Brno
4 Masarykův onkologický ústav, Brno

Pyridoxine dependent epilepsy is a rare autosomal recessive hereditary disorder causing a severe intractable epileptic seizures presenting

typically in prenatal and neonatal period, rarely in early infancy (age up to 3 years). Pyridoxine dependent epilepsy, caused by metabolic

disturbance of pyridoxine, is associated with mutations in ALDH7A1 or ALDH4A1 gene. Similar condition, pyridoxal-phosphate dependent

epilepsy (also called neonatal epileptic encephalopathy), is caused by mutations in PNPO gene. Pyridoxine dependent epilepsy

is successfully treatable using high doses of pyridoxine. Neonatal epileptic encephalopathy is refractory to pyridoxine administration,

however responses to treatment with pyridoxal-phosphate. The diagnosis of both pyridoxine dependent epilepsy and neonatal epileptic

encephalopathy is based on biochemical and genetic examinations.

Keywords: pyridoxine, pyridoxal-phosphate, pyridoxine-dependent epilepsy, pyridoxal-phosphate dependent epilepsy

Published: December 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Rusnáková Š, Fajkusová L, Jansová E, Šultesová P, Elstnerová L, Valík D, Ošlejšková H. Pyridoxine-dependent epilepsy - new trends in diagnosis and treatment. Neurol. praxi. 2010;11(5):327-330.
Download citation

References

  1. Bagci S, Zschocke J, Hoffmann GF, Bast T, Klepper J, Müller A, Heep A, Bartmann P, Franz AR. Pyridoxal phosphate-dependent neonatal epileptic encephalopathy. Arch Dis Child Fetal Neonatal Ed 2008; 93(2): 151-152. Go to original source... Go to PubMed...
  2. Baxter P. Pyridoxine-dependent seizures: a clinical and bio chemical conundrum. Biochim Biophys Acta 2003; 1647(1-2): 36-41. Go to original source... Go to PubMed...
  3. Bejšovec M, Kulenda Z, Ponča E. Familial Intrauterine Convulsions in Pyridoxine Dependency. Arch Dis Child 1967; 42 (222): 201-207. Go to original source... Go to PubMed...
  4. Bennett CL, Chen Y, Hahn S, Glass IA, Gospe SM. Prevalence of ALDH7A1 mutations in 18 North American pyridoxine-dependent seizure (PDS) patients. Epilepsia 2008; 50(5): 1167-1175. Go to original source... Go to PubMed...
  5. Farrant RD, Walker V, Mills GA, Mellor JM, Langley GJ. Pyridoxal Phosphate De-activation by Pyrroline-5-carboxylic Acid. Increased risk of vitamin B6 deficiency and seizures in hyperprolinemia type II. J Biol Chem 2001; 276(18): 15107-15116. Go to original source... Go to PubMed...
  6. Gospe SM. Pyridoxine-dependent seizures: new genetic and biochemical clues to help with diagnosis and treatment. Curr Opin Neurol 2006; 19(2): 148-153. Go to original source... Go to PubMed...
  7. Hoffmann GF, Schmitt B, Windfuhr M, Wagner N, Strehl H, Bagci S, Franz AR, Mills PB, Clayton PT, Baumgartner MR, Steinmann B, Bast T, Wolf NI, Zschocke J. Pyridoxal 5'-phosphate may be curative in early-onset epileptic encephalopathy. J Inherit Metab Dis 2007; 30(1): 96-99. Go to original source... Go to PubMed...
  8. Hunt AD, Stokes J, McCrory WW, Stroud HH. Pyridoxine dependency: report of a case of intractable convulsions in an infant controlled by pyridoxine. Paediatrics 1954; 13(2): 140-145. Go to original source...
  9. Khayat M, Korman SH, Frankel P, Weintraub Z, Hershckowitz S, Sheffer VF, Elisha MB, Wevers RA, Falik-Zaccai TC. PNPO deficiency: An under diagnosed inborn error of pyridoxine metabolism. Mol Genet Metab 2008; 94(4): 431-434. Go to original source... Go to PubMed...
  10. Kuo MF, Wang HS. Pyridoxal phosphate-responsive epilepsy with resistance to pyridoxine. Paediatr Neurol 2002; 26(2): 146-147. Go to original source... Go to PubMed...
  11. Parish A, Nissen MD, O´Neil C, Wilcox JA. Vitamin B-6 Dependency Syndromes. eMedicine Paediatrics 2008.
  12. Plecko B, Paul K, Paschke E, Stoeckler-Ipsiroglu S, Struys E, Jakobs C, Hartmann H, Luecke T, Capua M, Korenke C, Hikel C, Reutershahn E, Freilinger M, Baumeister F, Bosch F, Erwa W. Biochemical and Molecular Characterization of 18 Patients With Pyridoxine-Dependent Epilepsy and Mutations of the Antiquitin (ALDH7A1) Gene. Hum Mutat 2007; 28(1): 19-26. Go to original source... Go to PubMed...
  13. Mills PB, Surtees RAH, Champion MP, Beesley CE, Dalton N, Scambler PJ, Heales SJR, Briddon A, Scheimberg I, Hoffmann GF, Zschocke J, Clayton PT. Neonatal epileptic encephalopathy caused by mutations in the PNPO gene encoding pyridox (am) ine 5'-phosphate oxidase. Hum Mol Genet, 2005; 14(8): 1077-1086. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.